Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ossian Longoria
Observed names:
O Longoria-Lozano,
Ossian Longoria-Lozano
Institutions:
Royal Marsden NHS Foundation Trust,
Institute of Cancer Research,
Royal Marsden Hospital
Observed institutions:
Royal Marsden NHS Foundation Trust,
Institute of Cancer Research,
Universidad Autónoma de Nuevo León,
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,
Royal Marsden Hospital,
Universidad Nacional Autónoma de México
show all 6
ORCID:
0000-0002-0203-3987
Observed ORCID:
0000-0002-0203-3987
OpenAlex ID:
A5147494635
PARP inhibitors for prostate cancer
2023
·
Ossian Longoria
, Nick Beije
, et al.
·
Seminars in Oncology
·
34
Paclitaxel resistance is mediated by NF‑κB on mesenchymal primary breast cancer cells
2021
·
José Esparza‑lópez
, Ossian Longoria
, et al.
·
Oncology Letters
·
24
PDF
Natural history of longitudinally extensive transverse myelitis in 35 Hispanic patients with systemic lupus erythematosus: good short-term functional outcome and paradoxical increase in long-term mortality
2018
·
F D Flores-Silva
, O Longoria-Lozano
, et al.
·
Lupus
·
15
Genetic cancer predisposition syndromes among older adults
2020
·
Yanin Chavarri-Guerra
, Thomas P. Slavin
, et al.
·
Journal of Geriatric Oncology
·
14
Inducible nitric oxide synthase blockade with aminoguanidine, protects mice infected with Nocardia brasiliensis from actinomycetoma development
2020
·
Mario C. Salinas-Carmona
, Ossian Longoria-Lozano
, et al.
·
PLoS neglected tropical diseases
·
9
PDF
METRADS-P vs. RECIST/PCWG criteria to detect disease progression in metastatic castration-resistant prostate cancer (mCRPC).
2024
·
Nina Tunariu
, Giacomo Avesani
, et al.
·
Journal of Clinical Oncology
·
5
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular Subtypes
2025
·
Pasquale Rescigno
, Maria Dolores Fenor de la Maza
, et al.
·
European Urology Oncology
·
3
PDF
Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers
2026
·
Alec Paschalis
, Ines Figueiredo
, et al.
·
Journal of Clinical Investigation
·
1
Clinical and Molecular Profiles of Treatment-Emergent Small Cell Neuroendocrine Prostate Cancers in the Era of Intensified Systemic Therapies
2026
·
Nadeem Bilani
, Jesenia M. Perez
, et al.
·
Cancer Research Communications
PDF
Challenges of Using Circulating Tumour DNA: Insights from Advanced Prostate Cancer
2026
·
Tarek Taha
, Ossian Longoria
, et al.
·
European Urology
Comparative Assessment of METastasis Reporting and Data System for Prostate Cancer Versus Prostate Cancer Clinical Trials Working Group 3 Criteria in Assessing Treatment Response in Patients with Metastatic Castration-resistant Prostate Cancer
2026
·
Luca Russo
, Ossian Longoria
, et al.
·
European Urology Open Science
PDF
Molecular landscape of prostate cancers with clival metastases
2026
·
Pornlada Likasitwatanakul
, Steven M Blinka
, et al.
·
The Oncologist
Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancer
2025
·
Ossian Longoria
, Jan Rekowski
, et al.
·
JCI Insight
PDF
Abstract 1145: Morphological evaluation of chromosomal instability in circulating tumor cells and prediction of taxane resistance in metastatic prostate cancer: a prespecified sub-analysis of the CARD trial
2025
·
Ossian Longoria
, Jan Rekowski
, et al.
·
Cancer Research
Abstract 1416: Synergistic cytotoxicity of metformin cotreatment with paclitaxel or carboplatin in triple negative breast cancer cell lines
2021
·
Ossian Longoria
, José Esparza López
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
105
H-index:
5
I10-index:
4
Year
Topic
Type